Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United Kingdom
/
Healthcare
/
Integrated Diagnostics Holdings
IDHC
Integrated Diagnostics Holdings
Digital And House-Call Diagnostics Will Transform MENA Healthcare Delivery
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
27 Jul 25
Updated
27 Jul 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$0.91
61.5% undervalued
intrinsic discount
27 Jul
US$0.35
Loading
1Y
11.1%
7D
-2.8%
Author's Valuation
US$0.9
61.5% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$0.9
61.5% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
11b
2014
2017
2020
2023
2025
2026
2028
Revenue ج.م10.7b
Earnings ج.م2.0b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
17.09%
Healthcare Services revenue growth rate
0.30%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.53%
Calculation
ج.م2.03b
Earnings '28
x
14.02x
PE Ratio '28
=
ج.م28.53b
Market Cap '28
ج.م28.53b
Market Cap '28
/
528.72m
No. shares '28
=
ج.م53.95
Share Price '28
ج.م53.95
Share Price '28
Discounted to 2025 @ 6.53% p.a.
=
ج.م44.62
Fair Value '25
ج.م44.62
Fair Value '25
Converted to USD @ 0.02037 EGP/USD Exchange Rate
=
US$0.91
Fair Value '25